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Neocarzinostatin (NOS), a new anti-leukemic substance with a high
molecular weight, was first isolated from culture filtrates of Streptomyces
carzinostaticus (1). Its anti-leukemic activity has been demonstrated experi-
mentally in various mice leukemias (2,3). Its effect, however, on the immune
response has not been reported. Our preliminary data reported here on mice
indicates that NOS has a definitive effect on the production of hemolytic
plaque-forming cell (HPFO).
Mice used were 1.5-2.0 month-old 057BL males, weighing 20-22 g each.
The mice were sensitized by i. p. injection of 0.2 ml of 20% suspension of
sheep red blood cells (SRBC) on Day O. NOS at 1.0 mg/kg was injected i. p.
once to six different experimental groups: Group A-12 days prior to SRBO
injection; Group B-8 days prior to SRBO injection; Group 0-4 days prior
to SRBO injection; Group D-on the day of SRBC injection: Group E-2
days after SRBC injection and Group F-4 days after SRBC injection. Con-
trol mice were injected with 0.2 ml physiological saline solution. On day 5,
HPFC assay was perfonned according to the Cunningham and Szenberg (4)
plaque technique. As shown in Table 1, the mean HPFC per 106 spleen
cells was 348.6 in Group A, 8.9 in Group B, 8.8 in Group C, 265.9 in Group
D, 358.8 in Group E, 465.6 in Group F and 993.5 in the control group.
These results clearly show a moderate to marked decrease of HPFC
production regardless of the time duration between SRBC and NCS admini-
stration. NCS seems to have a suppressive effect as some alkylating agents.
The main anti-leukemic action of NCS has been thought to be through inhibi-
tion of DNA synthesis (5). However, our results suggest that NOS has a direct
cytotoxic action on leukemic cells apart from the inhibition of DNA synthesis.
However, further study including NOS effects on cellular immunity are
needed prior to definitive conclusions.
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TABLE 1 EFFECT OF NEOCARZINOSTATIN (NCSj ON HEMOLYTIC PLAQUE-FORMING
CELL (HPFC) PRODUCTION OF MICE TO SHEEP RED BLOOD CELL
NCS administration Number Total spleen HPFC per 106 HPFC per
on day of mice cell (x 106) spleen cells spleen (x 103)
-12 3 Ill. 7 348.6 49.9
(63.8-151. 3) (59.5-879.7) ( 3.8-133. I)
8 2 55.5 8.9 0.8
(21. 0-90.0) ( 0-17.8) ( 0-1.6)
4 3 56.7 8.8 0.6
(25.0-75.0) ( 0-18.5) ( 0-1. 3)
0 3 61. 3 265.9 20.4
(38.8-82.5) (64.4-608.6) ( 2.5-51.0)
+ 2 3 68.8 358.8 28.0(23.8-98.8) (6.1-965.4) ( 0.6-80.9)
+ 4 3 66.2 465.6 35.0(48.5-80.0) (62.9-1140.0) ( 4.4-91.2)
Control
(treated by saline) 3 84.6 993.5 85.6
(78.8-93.8) (630.7-1293.2) (49.7-121. 3)
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